Kymera Therapeutics (KYMR) Earnings
|
Expand Research on KYMR
| Next EPS Date | 7/31/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -10.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/31/26  |
Q226 | N/A | -$0.73 | N/A | N/A | $29.91M | N/A | N/A | N/A | ||
| 4/30/26 | Q126 | -$0.71 | -$0.88 | +$0.17 | $34.36M | $8.01M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$0.97 | -$0.79 | -$0.18 | $2.87M | $15M | N/A | | | Details | |
| 2/19/26 |
Q425 | N/A | -$0.79 | N/A | N/A | $15M | N/A | N/A | N/A | ||
| 11/4/25 | Q325 | -$0.94 | -$0.76 | -$0.18 | N/A | $23.8M | N/A | | | Details | |
| 8/11/25 | Q225 | -$0.95 | -$0.83 | -$0.12 | $11.48M | $20M | N/A | | | Details | |
| 8/1/25 |
Q225 | N/A | -$0.83 | N/A | N/A | $20M | N/A | N/A | N/A | ||
| 5/9/25 | Q125 | -$0.82 | -$0.89 | +$0.07 | $22.1M | $11.38M | N/A | | | Details |
